Medical Marijuana Turns 10: New Report to Examine Impact of California's Landmark Proposition 215

Submitted by Phillip Smith on
First Comprehensive Analysis of Medical Marijuana's Impact to Feature New Polling From All 11 Medical Marijuana States CONTACT: Bruce Mirken, MPP director of communications, 202-215-4205 or 415-668-6403 WASHINGTON, D.C. -- With the tenth anniversary of America's first effective medical marijuana law, California's Proposition 215, coming up Nov. 5, the Marijuana Policy Project (MPP) in Washington, D.C. is preparing to release the first-ever comprehensive analysis of the law's impact. Prop. 215 started a wave of medical marijuana laws now covering 11 states, including over 20 percent of the U.S. population. The report, to be issued approximately Oct. 26, will include: **New polling in all 11 medical marijuana states -- Alaska, California, Colorado, Hawaii, Maine, Montana, Nevada, Oregon, Rhode Island, Vermont, and Washington -- examining voter approval of the laws now that they have lived with them for a number of years. **Analysis of predictions made by Prop. 215's opponents, including then-White House Drug Czar Gen. Barry McCaffrey and U.S. Sen. Dianne Feinstein (D-CA), that the measure would increase teen drug use and effectively "legalize marijuana for everyone." **Profiles of real patients who have benefited from state medical marijuana laws, as well profiles of patients in states lacking such legal protection, who have "come out" in an effort to reform their states' laws. Journalists wishing to receive an embargoed copy of the report in advance of the official release date should contact MPP Director of Communications Bruce Mirken at [email protected]. With more than 20,000 members and 100,000 e-mail subscribers nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. MPP believes that the best way to minimize the harm associated with marijuana is to regulate marijuana in a manner similar to alcohol. For more information, please visit ####
Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.

Source URL: